Traws Pharma, Inc.TRAWNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+38.6%
5Y CAGR+28.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+38.6%/yr
Annual compound
5Y CAGR
+28.6%/yr
Recent acceleration
Percentile
P92
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 35.13% |
| 2023 | 7.66% |
| 2022 | -10.38% |
| 2021 | 13.20% |
| 2020 | -0.23% |
| 2019 | 10.01% |
| 2018 | 2.44% |
| 2017 | -18.47% |
| 2016 | -3.21% |
| 2015 | -36.10% |